{"title":"Identifying key risk factors for severe pediatric anaphylaxis in children aged 0 to 15: Evidence from a Thai study.","authors":"Treesupak Kawsomboon, Pasuree Sangsupawanich, Vanlaya Koosakulchai, Pornruedee Ratchatawiriyakul, Bunrat Srisuk, Araya Yuenyongviwat","doi":"10.5415/apallergy.0000000000000210","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anaphylaxis is a life-threatening condition with significant global health implications. Understanding its risk factors in children across diverse populations is crucial for effective prevention and management strategies.</p><p><strong>Objective: </strong>The aim is to identify risk factors for severe anaphylaxis in children, using data from a Southeast Asian population.</p><p><strong>Methods: </strong>A retrospective study was conducted at a tertiary care hospital, Thailand, from 2015 to 2023. Data from 335 pediatric patients with anaphylaxis, classified into severe and nonsevere groups, were analyzed. Risk factors were identified using multivariable logistic regression.</p><p><strong>Results: </strong>Severe anaphylaxis occurred in 24 patients (7.2%). Males (58%) and food allergens, particularly shellfish and wheat, were the predominant factors. Severe cases were associated with an age greater than 12 years (adjusted odds ratio [aOR]: 5.67, <i>P</i> < 0.05), cardiovascular manifestations (aOR: 129.94, <i>P</i> < 0.01), and an early onset of symptoms (aOR: 0.96, <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>Age >12 years, cardiovascular symptoms, and early symptom onset were significant risk factors for severe anaphylaxis in children. These findings highlight the need for heightened vigilance and tailored management strategies in older children and those with cardiovascular involvement. Future studies in diverse populations are needed to confirm the generalizability of these risk factors.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"15 3","pages":"192-197"},"PeriodicalIF":2.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12419435/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Pacific Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5415/apallergy.0000000000000210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Anaphylaxis is a life-threatening condition with significant global health implications. Understanding its risk factors in children across diverse populations is crucial for effective prevention and management strategies.
Objective: The aim is to identify risk factors for severe anaphylaxis in children, using data from a Southeast Asian population.
Methods: A retrospective study was conducted at a tertiary care hospital, Thailand, from 2015 to 2023. Data from 335 pediatric patients with anaphylaxis, classified into severe and nonsevere groups, were analyzed. Risk factors were identified using multivariable logistic regression.
Results: Severe anaphylaxis occurred in 24 patients (7.2%). Males (58%) and food allergens, particularly shellfish and wheat, were the predominant factors. Severe cases were associated with an age greater than 12 years (adjusted odds ratio [aOR]: 5.67, P < 0.05), cardiovascular manifestations (aOR: 129.94, P < 0.01), and an early onset of symptoms (aOR: 0.96, P < 0.05).
Conclusion: Age >12 years, cardiovascular symptoms, and early symptom onset were significant risk factors for severe anaphylaxis in children. These findings highlight the need for heightened vigilance and tailored management strategies in older children and those with cardiovascular involvement. Future studies in diverse populations are needed to confirm the generalizability of these risk factors.
期刊介绍:
Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.